Skip to main content
. Author manuscript; available in PMC: 2013 Jul 22.
Published in final edited form as: PM R. 2012 Nov 14;5(5):408–417. doi: 10.1016/j.pmrj.2012.09.578

Table 1.

Baseline characteristics of male veterans discharged home

Total
1480
Discharged Home
n (%)
N = 1163 (78.6%)
Not Discharged Home
n (%)
N = 317 (21.4%)
Patient-level
  Demographics
    Marital status*
      Married 687 562 (81.8) 125 (18.2)
      Not married 793 601 (75.8) 192 (24.2)
    Living location before hospitalization
      Home 1360 1123 (82.6) 237 (17.4)
      Extended care or hospital 120 40 (33.3) 80 (66.7)
  Amputation type
    Unilateral transtibial 771 606 (78.6) 165 (21.4)
    Unilateral transfemoral 592 458 (77.4) 134 (22.6)
    Bilateral transtibial 38 32 (84.2) 6 (15.8)
    High-level bilateral transfemoral 79 67 (84.8) 12 (15.2)
  Amputation etiologies
    Chronic osteomyelitis
      Yes 105 87 (82.9) 18 (17.1)
      No 1375 1076 (78.3) 299 (21.8)
    Device infection
      Yes 164 137 (83.5) 27 (16.5)
      No 1316 1026 (78.0) 290 (22.0)
    Diabetes mellitus type 1
      Yes 246 187 (76.0) 59 (24.0)
      No 1234 976 (79.1) 258 (20.9)
    Diabetes mellitus type 2
      Yes 998 782 (78.4) 216 (21.6)
      No 482 381 (79.1) 101 (21.0)
    Local significant infection*
      Yes 1144 875 (76.5) 269 (23.5)
      No 336 288 (85.7) 48 (14.3)
    Peripheral vascular disease
      Yes 1291 1004 (77.8) 287 (22.2)
      No 189 159 (84.1) 30 (15.9)
    Previous amputation complication
      Yes 139 113 (81.3) 26 (18.7)
      No 1341 1050 (78.3) 291 (21.7)
    Skin breakdown
      Yes 954 741 (77.7) 213 (22.3)
      No 526 422 (80.2) 104 (19.8)
    Systemic sepsis
      Yes 132 96 (72.7) 36 (27.3)
      No 1348 1067 (79.2) 281 (20.9)
    Trauma
      Yes 209 162 (77.5) 47 (22.5)
      No 1271 1001 (78.8) 270 (21.2)
  Comorbidities
    AIDS
      Yes 12 9 (75.0) 3 (25.0)
      No 1468 1154 (78.6) 314 (21.4)
    Alcohol abuse
      Yes 83 63 (75.9) 20 (24.1)
      No 1397 1100 (78.7) 297 (21.3)
    Arrhythmias
      Yes 231 174 (75.3) 57 (24.7)
      No 1249 989 (79.2) 260 (20.8)
    Chronic blood loss anemia
      Yes 28 20 (71.4) 8 (28.6)
      No 1452 1143 (78.7) 309 (21.3)
    Chronic pulmonary disease*
      Yes 293 212 (72.4) 81 (27.7)
      No 1187 951 (80.1) 236 (19.9)
    Coagulopathy
      Yes 68 54 (79.4) 14 (20.6)
      No 1412 1109 (78.5) 303 (21.5)
    Congestive heart failure*
      Yes 310 219 (70.7) 91 (29.4)
      No 1170 944 (80.7) 226 (19.3)
    Deficiency anemia
      Yes 324 252 (77.8) 72 (22.2)
      No 1156 911 (78.80 245 (21.2)
    Depression
      Yes 134 97 (72.4) 37 (27.6)
      No 1346 1066 (79.2) 280 (20.8)
    Drug abuse
      Yes 33 30 (90.9) 3 (9.1)
      No 1447 1133 (78.3) 314 (21.7)
    Fluid and electrolyte disorders
      Yes 284 215 (75.7) 69 (24.3)
      No 1196 948 (79.3) 248 (20.7)
    Hypertension
      Yes 959 758 (79.0) 201 (21.0)
      No 521 405 (77.7) 116 (22.3)
    Hypertension with complication
      Yes 8 8 (100.0) 0
      No 1472 1155 (78.5) 317 (21.5)
    Hypothyroidism
      Yes 51 37 (72.6) 14 (27.5)
      No 1429 1126 (78.8) 303 (21.2)
    Liver disease
      Yes 52 39 (75.0) 13 (25.0)
      No 1428 1124 (78.7) 304 (21.3)
    Lymphoma
      Yes 10 8 (80.0) 2 (20.0)
      No 1470 1155 (78.6) 315 (21.4)
    Metastatic cancer
      Yes 27 17 (63.0) 10 (37.0)
      No 1453 1146 (78.9) 307 (21.1)
    Other neurologic disorders
      Yes 39 26 (66.7) 13 (33.3)
      No 1441 1137 (78.9) 304 (21.1)
    Paralysis
      Yes 62 54 (87.1) 8 (12.9)
      No 1418 1109 (78.2) 309 (21.8)
    Peptic ulcer
      Yes 18 13 (72.2) 5 (27.8)
      No 1462 1150 (78.7) 312 (21.3)
    Psychosis
      Yes 105 77 (73.3) 28 (26.7)
      No 1375 1086 (79.0) 289 (21.0)
    Pulmonary circulation disease
      Yes 10 8 (80.0) 2 (20.0)
      No 1470 1155 (78.6) 315 (21.4)
    Renal failure
      Yes 235 178 (75.7) 57 (24.3)
      No 1245 985 (79.1) 260 (20.9)
    Rheumatoid arthritis
      Yes 14 12 (85.7) 2 (14.3)
      No 1466 1151 (78.5) 315 (21.5)
    Solid tumor without metastasis
      Yes 126 92 (73.0) 34 (27.0)
      No 1354 1071 (79.1) 283 (20.9)
    Valvular disease
      Yes 49 34 (69.4) 15 (30.6)
      No 1431 1129 (78.9) 302 (21.1)
    Weight loss
      Yes 72 56 (77.8) 16 (22.2)
      No 1408 1107 (78.6) 301 (21.4)
Treatment-level
  Procedures
    Active pulmonary pathology
      Yes 10 8 (80.0) 2 (20.0)
      No 1470 1155 (78.6) 315 (21.4)
    Acute central nervous system
      Yes 111 87 (78.4) 24 (21.6)
      No 1369 1076 (78.6) 293 (21.4)
    Ongoing active cardiac pathology*
      Yes 164 113 (68.9) 51 (31.1)
      No 1316 1050 (79.8) 266 (20.2)
    Ongoing wound problems
      Yes 92 66 (71.7) 26 (28.3)
      No 1388 1097 (79.0) 291 (21.0)
    Serious nutritional compromise*
      Yes 44 25 (56.8) 19 (43.2)
      No 1436 1138 (79.3) 298 (20.8)
    Severe renal disease
      Yes 107 80 (74.8) 27 (25.2)
      No 1373 1083 (78.9) 290 (21.1)
    Substance abuse/mental health issues
      Yes 21 16 (76.2) 5 (23.8)
      No 1459 1147 (76.6) 312 (21.4)
    Inpatient rehabilitation type*
      Consultative rehabilitation 1140 877 (76.9) 263 (23.1)
      Specialized rehabilitation 340 286 (84.1) 54 (15.9)
Facility-level
  Geographic regions
    Northeast 212 160 (75.5) 52 (24.5)
    Southeast 464 380 (81.9) 84 (18.1)
    Midwest 214 167 (78.0) 47 (22.0)
    South Central 359 302 (84.1) 57 (15.9)
    Pacific Mountain 231 154 (66.7) 77 (33.3)
  Total hospital bed size
    Bed size ≤ 126 390 325 (83.3) 65 (16.7)
    Bed size 127–244 437 337 (77.1) 100 (22.9)
    Bed size 245–362 547 424 (77.5) 123 (22.5)
    Bed size >362 106 77 (72.6) 29 (27.4)
*

P < .01;

P < .0001;

P < .05.